Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Natural Compound Methylnissolin: Physicochemical Properties, Pharmacological Activities, Pharmacokinetics and Resource Development. | Drug Des Devel Ther | 2025 | 40356679 | PubTator, text mining | PubMed |
| Epigenetics of maternal-fetal interface immune microenvironment and placental related pregnancy complications. | Front Immunol | 2025 | 40248704 | PubTator, text mining | PubMed |
| RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination. | Cell Death Dis | 2025 | 40185717 | PubTator, text mining | PubMed |
| Ubiquitin Ligases in Control: Regulating NLRP3 Inflammasome Activation. | Front Biosci (Landmark Ed) | 2025 | 40152367 | PubTator, text mining | PubMed |
| Prodrug Approach as a Strategy to Enhance Drug Permeability. | Pharmaceuticals (Basel) | 2025 | 40143076 | PubTator, text mining | PubMed |
| ImmunoMet Oncogenesis: A New Concept to Understand the Molecular Drivers of Cancer. | J Clin Med | 2025 | 40095546 | PubTator, text mining | PubMed |
| Effects of Global Ripk2 Genetic Deficiency in Aged Mice following Experimental Ischemic Stroke. | bioRxiv | 2025 | 39974926 | PubTator, text mining | PubMed |
| Ablation of the deubiquitinating enzyme cylindromatosis (CYLD) augments STAT1-mediated M1 macrophage polarization and fosters Staphylococcus aureus control. | Front Immunol | 2025 | 39958342 | PubTator, text mining | PubMed |
| [Analgesic effect of "Zhibian" (BL54)-toward-"Shuidao" (ST28) needling technique of acupuncture on primary dysmenorrhea based on NOD1/RIP2/NF-κB signaling pathway in the rats]. | Zhongguo Zhen Jiu | 2025 | 39943763 | PubTator, text mining | PubMed |
| Apaf-1 is an evolutionarily conserved DNA sensor that switches the cell fate between apoptosis and inflammation. | Cell Discov | 2025 | 39833169 | PubTator, text mining | PubMed |
| Mitochondrial-associated programmed-cell-death patterns for predicting the prognosis of non-small-cell lung cancer. | Front Med | 2025 | 39576480 | PubTator, text mining | PubMed |
| RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis. | Transl Oncol | 2025 | 39515087 | PubTator, text mining | PubMed |
| A derivative of tanshinone IIA and salviadione, 15a, inhibits inflammation and alleviates DSS-induced colitis in mice by direct binding and inhibition of RIPK2. | Acta Pharmacol Sin | 2025 | 39443729 | PubTator, text mining | PubMed |
| Towards New Anti-Inflammatory Agents: Design, Synthesis and Evaluation of Molecules Targeting XIAP-BIR2. | ChemMedChem | 2025 | 39364702 | PubTator, text mining | PubMed |
| CARTp/GPR160 mediates behavioral hypersensitivities in mice through NOD2. | Pain | 2025 | 39356206 | PubTator, text mining | PubMed |
| Understanding a point mutation signature D54K in the caspase activation recruitment domain of NOD1 capitulating concerted immunity via atomistic simulation. | J Biomol Struct Dyn | 2025 | 38415678 | PubTator, text mining | PubMed |
| Investigating the impact of inflammatory response-related genes on renal fibrosis diagnosis: a machine learning-based study with experimental validation. | J Biomol Struct Dyn | 2025 | 38381715 | PubTator, text mining | PubMed |
| Negative Pressure Wound Therapy Promotes Wound Healing by Inhibiting Inflammation in Diabetic Foot Wounds: A Role for NOD1 Receptor. | Int J Low Extrem Wounds | 2025 | 36221954 | PubTator, text mining | PubMed |
| Receptor interacting serine/threonine kinase 2 promotes rheumatoid arthritis progression and partially regulates nuclear factor kappa B pathway. | Cytojournal | 2024 | 39737123 | PubTator, text mining | PubMed |
| Analysis of immune cell activation in patients with diabetes foot ulcer from the perspective of single cell. | Eur J Med Res | 2024 | 39702546 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=5